Immunome Inc. Business Finance Contracts & Agreements

26 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Immunome, Inc. Executive Stock Option Grant Notice and Stock Option Agreement (2020 Equity Incentive Plan)
Equity Distribution Agreements
Immunome Inc.
Biotechnology
2025
Underwriting Agreement between Immunome, Inc. and Underwriters for Common Stock Offering (January 29, 2025)
Underwriting Agreements
Immunome Inc.
Biotechnology
NY
2025
Stock Issuance Agreement between Immunome, Inc. and Zentalis Pharmaceuticals, Inc. dated October 25, 2024
Stock Agreements
Immunome Inc.
Biotechnology
DE
2024
Asset Purchase Agreement among Zentalis Pharmaceuticals, Inc., Zeno Management, Inc., and Immunome, Inc. dated October 25, 2024
Purchase Agreements
Immunome Inc.
Biotechnology
WA
2024
Sales Agreement between Immunome, Inc. and TD Securities (USA) LLC for Up to $200,000,000 of Common Stock
Equity Distribution Agreements
Immunome Inc.
Biotechnology
NY
2024
Asset Purchase Agreement between Atreca, Inc. and Immunome, Inc. dated December 22, 2023
Purchase Agreements
Immunome Inc.
Biotechnology
DE
2024
Underwriting Agreement between Immunome, Inc. and J.P. Morgan Securities LLC, Cowen and Company, LLC, Leerink Partners LLC, and Guggenheim Securities, LLC
Underwriting Agreements
Immunome Inc.
Biotechnology
NY
2024
Asset Purchase Agreement between Ayala Pharmaceuticals, Inc. and Immunome, Inc. dated February 5, 2024
Purchase Agreements
Immunome Inc.
Biotechnology
NJ
2024
Immunome, Inc. 2020 Equity Incentive Plan (as Amended)
Equity Distribution Agreements
Immunome Inc.
Biotechnology
DE
2023
Morphimmune Inc. 2020 Equity Incentive Plan Stock Option Agreement
Warrant Agreements
Immunome Inc.
Biotechnology
DE
2023
Morphimmune Inc. 2020 Equity Incentive Plan (as Amended)
Equity Distribution Agreements
Immunome Inc.
Biotechnology
DE
2023
Immunome, Inc. Subscription Agreement with Investors for Private Placement of Common Stock
Subscription Agreements
Immunome Inc.
Biotechnology
2023
Amendment No. P00004 to Contract W911QY2090019 between ACC-APG Edgewood and Immunome, Inc.
Modification Agreements
Immunome Inc.
Biotechnology
2023
Description of Capital Stock, Warrants, and Registration Rights of [Company Name]
Equity Distribution Agreements
Immunome Inc.
Biotechnology
2023
Immunome, Inc. Notice of Amendment to Series B Warrants Dated April 28, 2021
Warrant Agreements
Immunome Inc.
Biotechnology
2022
Amendment to Contract W911QY2090019 Between Immunome, Inc. and U.S. Army (Completion Date Extension)
Modification Agreements
Immunome Inc.
Biotechnology
2022
Description of Capital Stock, Warrants, and Registration Rights of [Company Name]
Equity Distribution Agreements
Immunome Inc.
Biotechnology
2022
Contract Modification Agreement Increasing Funding and Extending Completion Date (W911QY2090019)
Modification Agreements
Immunome Inc.
Biotechnology
2021
Placement Agent Engagement Agreement between Immunome, Inc. and Ladenburg Thalmann & Co. Inc. (April 9, 2021)
Underwriting Agreements
Immunome Inc.
Biotechnology
NY
2021
Securities Purchase Agreement between Immunome, Inc. and Purchasers dated April 26, 2021
Purchase Agreements
Immunome Inc.
Biotechnology
NY
2021
Immunome, Inc. Series B Warrant to Purchase Common Stock Agreement with Holder
Warrant Agreements
Immunome Inc.
Biotechnology
NY
2021
Description of Capital Stock, Registration Rights, and Anti-Takeover Provisions of [Company Name]
Registration Rights Agreements
Immunome Inc.
Biotechnology
2021
Immunome, Inc. Stock Option Grant Notice and Agreement (2020 Equity Incentive Plan)
Equity Distribution Agreements
Immunome Inc.
Biotechnology
2020
Amendment to 2020 Series A Preferred Stock Warrants by Immunome, Inc.
Warrant Agreements
Immunome Inc.
Biotechnology
DE
2020
Immunome, Inc. Common Stock Certificate
Stock Agreements
Immunome Inc.
Biotechnology
2020
Underwriting Agreement between Immunome, Inc. and Ladenburg Thalmann & Co. Inc. and Chardan Capital Markets, LLC
Underwriting Agreements
Immunome Inc.
Biotechnology
NY
2020